Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.Ogawa, Hisao; Nakayama, Masafumi; Morimoto, Takeshi; Uemura, Shiro; Kanauchi, Masao; Doi, Naofumi; Jinnouchi, Hideaki; Sugiyama, Seigo; Saito, YoshihikoJAMA : the journal of the American Medical Association; 2008 Nov 12;300(18):2134-41. PMID: 18997198Category: GuidelinesTags: cardiovascular diseasepatient caretype 2 diabetesLinks: PubMed ArticleJournal ArticleAbstractPrevious trials have investigated the effects of low-dose aspirin on primary prevention of cardiovascular events, but not in patients with type 2 diabetes.